Advisory Research’s G Squared Ascend I Inc. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 GSQD.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-102,500
Closed -$41K 454
2022
Q1
$41K Hold
102,500
﹤0.01% 368
2021
Q4
$88K Buy
102,500
+72,500
+242% +$80.9K 0.01% 320
2021
Q3
$31K Buy
+30,000
New +$31.5K ﹤0.01% 340

Other funds holding GSQD.WS

Advisory Research's GSQD.WS Position: Q2 2022 in Review

Advisory Research sold out of G Squared Ascend I Inc. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 (GSQD.WS) in Q2 2022, closing a stake of 102,500 shares — an estimated $41K sold.

Advisory Research first reported a position in GSQD.WS in Q3 2021 and held it in 3 quarters. The position peaked at $88K in Q4 2021. 40 funds tracked by Wall St. Rank hold GSQD.WS as of Q2 2022.

  • Advisory Research reported no remaining G Squared Ascend I Inc. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 position as of Q2 2022 after selling out during the quarter.
  • Advisory Research sold 102,500 G Squared Ascend I Inc. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 shares in Q2 2022, an estimated $41K.
  • Advisory Research first reported a position in G Squared Ascend I Inc. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 in Q3 2021 and held it in 3 quarters.
  • Advisory Research's G Squared Ascend I Inc. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 position peaked at $88K in Q4 2021.
  • 40 funds tracked by Wall St. Rank held G Squared Ascend I Inc. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 as of Q2 2022.

Based on Advisory Research's 13F filing for Q2 2022, filed 15 Aug 2022.